Abagre TA, Bandoh DA, Addo-Lartey AA. Determinants of metabolic syndrome among patients attending diabetes clinics in two sub-urban hospitals: Bono Region Ghana. BMC Cardiovasc Disord. 2022;22(366):1–13. https://doi.org/10.1186/s12872-022-02805-4.
Ahmed HS. Correlations between serum interleukins-2,-4 levels and some biochemical parameters in Iraqi patients with osteoporosis. Fac Med Baghdad. 2017;59(3):275–9. https://doi.org/10.32007/jfacmedbagdad.593103.
Ahmed HS. Serum adropin and apelin as potential markers predicting acute heart failure-associated renal dysfunction among elderly Iraqi patients. Ann Trop Med Public Health. 2020;23(10):1–15. https://doi.org/10.36295/asro.2020.231024.
Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J, James WBT, Loria CM, Smith Jr SC, International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, American Heart Association; World Heart Federation, International Atherosclerosis Society, and International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; and international. Circulation. 2009;120(16):1640–1645. (Epub 2009 Oct 5).
An C, Wang H, Liu X, Li Y, Su Y, Gao X, Jiang W. Serum retinol binding protein 4 is elevated and positively associated with insulin resistance in postmenopausal women. Endocr J. 2009;56(8):987–96. https://doi.org/10.3390/ijms21155229.
Article CAS PubMed Google Scholar
Banik SD, Pacheco-Pantoja E, Lugo R, Gomez-de-Regil L, Chim Ake R, Mendez Gonzalez RM, Solis ALG. Evaluation of anthropometric indexes and lipid parameters to predict metabolic syndrome among adults in Mexico. Diabetes Metab Syndr Obes. 2021;2021(14):691–701. https://doi.org/10.2147/DMSO.S281894.
Chu SY, Jung JH, Park MJ, Kim SH. Risk assessment of metabolic syndrome in adolescents using the triglyceride/high density lipoprotein cholesterol ratio and the total cholesterol/high-density lipoprotein cholesterol ratio. Ann Pediatr Endocrinol Metab. 2019;24(1):41–8. https://doi.org/10.6065/apem.2019.24.1.41.
Article PubMed PubMed Central Google Scholar
Cin NNA, Yardımci H, Koc N, Uçakturk SA, Ok MA. Triglycerides/high-density lipoprotein cholesterol is a predictor similar to the triglyceride-glucose index for the diagnosis of metabolic syndrome using international diabetes federation criteria of insulin resistance in obese adolescents: a cross-sectional study. J Pediatr Endocrinol Metab. 2020;33(6):777–84. https://doi.org/10.1515/jpem-2019-0310.
Do R, Willer CJ, Schmidt EM, Sengupta S, Gao C, Peloso GM. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet. 2013;45(11):1345–52. https://doi.org/10.1038/ng.2795. (Epub 2013 Oct 6).
Article CAS PubMed PubMed Central Google Scholar
Dobiasova M, Frohlich J. The plasma parameter log (TG/HDLC) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FERHDL). Clin Biochem. 2001;34(7):583–8. https://doi.org/10.1016/s0009-9120(01)00263-6.
Article CAS PubMed Google Scholar
Dobiasova M. AIP-atherogenic index of plasma as a significant predictor of cardiovascular risk: From research to practice. Vnitr Lek. 2006;52(1):64–71.
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415–28. https://doi.org/10.1016/S0140-6736(05)66378-7.
Article CAS PubMed Google Scholar
Essiarab F, Taki H, Lebrazi H, Sabri M, Saile R. Usefulness of lipid ratios and atherogenic index of plasma in obese Moroccan women with or without metabolic syndrome. Ethn Dis. 2014;24(2):207–12.
Gadde KM, Martin CK, Berthoud H-R, Heymsfield SB. Obesity, pathophysiology and management. J Am Coll Cardiol. 2018;71(1):69–84. https://doi.org/10.1016/j.jacc.2017.11.011.
Article PubMed PubMed Central Google Scholar
Ghyselinck NB, Duester G. Retinoic acid signaling pathways. Development. 2019;146(13):dev.67502. https://doi.org/10.1242/dev.167502.
Ginsberg HN. New perspectives on atherogenesis: Role of abnormal triglyceride-rich lipoprotein metabolism. Circulation. 2002;106(16):2137–42. https://doi.org/10.1161/01.CIR.0000035280.64322.31.
Goossens GH, Jocken JWE, Blaak EE. Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver. Nat Rev Endocrinol. 2021;17(1):47–66. https://doi.org/10.1038/s41574-020-00431-8.
Hamza MA, AL-Tamer YY, AL-Habib OA. Modification of irisin level in overweight/obese women during pregnancy and its association with some metabolic risk factors. Baghdad Sci J. 2020;17(3):1124–32.
Hermans MP, Sacks FM, Ahn SA, Rousseau MF. Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: discriminant ratio and unbiased equivalence. Cardiovasc Diabetol. 2011;10(20):1–7. https://doi.org/10.1186/1475-2840-10-20.
Karamfilova V, Gateva A, Alexiev A, Zheleva N, Velikova T, Ivanova-Boyanova R, Ivanova R, Cherkezov N, Kamenov Z, Mateva L. The association between retinol-binding protein 4 and prediabetes in obese patients with nonalcoholic fatty liver disease. Arch Physiol Biochem. 2022;128(1):217–22. https://doi.org/10.1080/13813455.2019.1673429.
Article CAS PubMed Google Scholar
Kilicarslan M, de Weijer BA, Simonyte Sjodin K, Aryal P, Ter Horst KW, Cakir H, Brzozowska A, Szybalska A, Puzianowska-Kuznicka M, Grodzicki T, Więcek A, Olszanecka-Glinianowicz M, Chudek J. RBP4 increases lipolysis in human adipocytes and is associated with increased lipolysis and hepatic insulin resistance in obese women. FASEB J. 2020;34(5):6099–110. https://doi.org/10.1096/fj.201901979RR.
Article CAS PubMed Google Scholar
Krawczyk M, Ruminska M, Witkowska-Sedek E, Majcher A, Pyrzak B. Usefulness of the triglycerides to high-density lipoprotein cholesterol ratio (TG/HDL-C) in prediction of metabolic syndrome in polish obese children and adolescents. Acta Biochim Pol. 2018;65(4):605–11. https://doi.org/10.18388/abp.2018_2649.
Article CAS PubMed Google Scholar
Li N, Fu J, Koonen DP, Kuivenhoven JA, Snieder H, Hofker MH. Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance? Atherosclerosis. 2014;233(1):130–8. https://doi.org/10.1016/j.atherosclerosis.2013.12.013.
Article CAS PubMed Google Scholar
Lima VC, Lyra CO, Pinheiro LGB, de Azevedo PRM, Arrais RF, Pedrosa LFC. Association between dyslipidemia and anthropometric indicators in adolescents. Nutr Hosp. 2011;26(2):304–10. https://doi.org/10.1590/S0212-16112011000200010.
Majerczyk M, Kocełak P, Choręza P, Arabzada H, Owczarek AJ, Bozentowicz-Wikarek M, Brzozowska A, Szybalska A, Puzianowska-Kuźnicka M, Grodzicki T, Więcek A, Olszanecka-Glinianowicz M, Chudek J. Components of metabolic syndrome in relation to plasma levels of retinol binding protein 4 (RBP4) in a cohort of people aged 65 years and older. J Endocrinol Investig. 2018;41(10):1211–9. https://doi.org/10.1007/s40618-018-0856-6.
Mateo-Gallego R, Lamiquiz-Moneo I, Perez-Calahorra S, Marco-Benedi V, Bea AM, Baila-Rueda L, Laclaustra M, Penalvo JL, Civeira F, Cenarro A. Different protein composition of low-calorie diet differently impacts adipokine profile irrespective of weight loss in overweight and obese women. Nutr Metab Cardiovasc Dis. 2019;28(2):133–42. https://doi.org/10.1016/j.numecd.2017.10.024.
Mogre V, Salifu ZS, Abedandi R. Prevalence, components and associated demographic and lifestyle factors of the metabolic syndrome in type 2 diabetes mellitus. J Diabetes Metab Disord. 2014;13(1):80. https://doi.org/10.1186/2251-6581-13-80.
Article PubMed PubMed Central Google Scholar
Moraes-Vieira PM, Yore MM, Sontheimer-Phelps A, Castoldi A, Norseen J, Aryal P, Sjodin KS, Kahn BB. Retinol binding protein 4 primes the NLRP3 inflammasome by signaling through Toll-like receptors 2 and 4. Proc Natl Acad Sci USA. 2020;117(49):31309–18. https://doi.org/10.1073/pnas.2013877117.
Article CAS PubMed PubMed Central Google Scholar
Nankam NPA, Bluher M. Retinol-binding protein 4 in obesity and metabolic dysfunctions. Mol Cell Endocrinol. 2021;531(111312):1–14. https://doi.org/10.1016/j.mce.2021.111312.
Nie G, Hou S, Zhang M, Peng W. High TG/HDL ratio suggests a higher risk of metabolic syndrome among an elderly Chinese population: a cross-sectional study. BMJ Open. 2021;11(3):e041519. https://doi.org/10.1136/bmjopen-2020-041519.
Article PubMed PubMed Central Google Scholar
Noh MFM, Gunasegavan RDN, Mustar S. Vitamin A in health and disease. Vitamin A. 2019. https://doi.org/10.5772/intechopen.84460.
Radetti G, Fanolla A, Grugni G, Lupi F, Sartorio A. Indexes of adiposity and body composition in the prediction of metabolic syndrome in obese children and adolescents: Which is the best? Nutr Metab Cardiovasc Dis. 2019;29(11):1189–96. https://doi.org/10.1016/j.numecd.2019.06.011.
Rajaei E, Jalali MT, Shahrabi S, Asnafi AA, Pezeshki SMS. HLAs in autoimmune diseases: dependable diagnostic biomarkers? Curr Rheumatol Rev. 2019;15(4):269–76. https://doi.org/10.2174/1573397115666190115143226.
Article CAS PubMed Google Scholar
Raoof EM, Ahmed HS. Circulating adipsin as biomarker and its implication in type 2 diabetes mellitus. IJDDT. 2022;12(2):588–93.
Reaven GM. Banting lecture. Role of insulin resistance in human disease. Nutrition. 1988;37(12):1595–607.
Sadiq GH, Hussein RH, Maulood IM. Ghrelin and leptin and their relations with insulin resistance in diabetes mellitus type 2 patients. Baghdad Sci J. 2022;19(1):33–42.
Salman ED, Ahmed HS. Bone mineral density and vitamin D status among postmenopausal Iraqi women. Plant Arch. 2020;20(2):4613–20.
Sheth J, Shah A, Sheth F, Trivedi S, Nabar N, Shah N, Thakor P, Vaidya R. The association of dyslipidemia and obesity with glycated hemoglobin. Clin Diabetes Endocrinol. 2015;1(1):1–7. https://doi.org/10.1186/s40842-015-0004-6.
Steinhoff JS, Lass A, Schupp M. Biological functions of RBP4 and its relevance for human diseases. Front Physiol. 2021;12(659977):1–15. https://doi.org/10.3389/fphys.2021.659977.
Comments (0)